This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pennanen, S. Articles by Komulainen, H. Search for Related Content PubMed PubMed Citation Articles by Pennanen, S. Articles by Komulainen, H. Social Bookmarking                   What's this?

CYP enzymes catalyze the formation of a terminal olefin from 2-ethylhexanoic acid in rat and human liver

National Public Health Institute, Division of Environmental Health, P.O.B. 95, FIN-70701 Kuopio, Finland

A. Kojo

Department of Pharmacology and Toxicology, University of Kuopio, P.O.B. 1627, FIN-70211, Kuopio, Finland

M. Pasanen

Department of Pharmacology and Toxicology, University of Kuopio, P.O.B. 1627, FIN-70211, Kuopio, Finland

J. Liesivuori

Kuopio Regional Institute of Occupational Health, P.O.B. 95, FIN-70701 Kuopio, Finland

RO Juvonen

Department of Pharmacology and Toxicology, University of Kuopio, P.O.B. 1627, FIN-70211, Kuopio, Finland

H. Komulainen

National Public Health Institute, Division of Environmental Health, P.O.B. 95, FIN-70701 Kuopio, Finland, Department of Pharmacology and Toxicology, University of Kuopio, P.O.B. 1627, FIN-70211, Kuopio, Finland

1 The metabolism of 2-ethylhexanoic acid (2-EHA) was studied in rat, mouse and human liver microsomes in vitro. The metabolites of 2-EHA were identified as methylated derivatives by gas chromatography-mass spectrometry.

2 2-Ethyl-1,6-hexanedioic acid was the main metabolite produced in rat, mouse and human liver microsomes. Unsaturated 2-ethyl-5-hexenoic acid, a terminal ole fin, was produced only in human liver microsomes and phenobarbital-induced rat liver microsomes. The cytochrome P450 (CYP) inhibitors metyrapone, SKF 525A, triacetyloleandomycin (TAO), quinidine and the cytochrome P450 reductase antibody abolished its formation both in rat and human microsomes.

3 The metabolites were analyzed also in vivo in urine of 2-EHA-exposed rats and in urine of sawmill workers exposed occupationally to 2-EHA. Both rat and human urine contained 2-ethyl-1,6-hexanedioic acid as the main metabolite and also 2-ethyl-5-hexenoic acid. Metyrapone, SKF 525A and TAO all decreased drastically the formation of 2-ethyl-5-hexenoic acid in the rat.

4 The data indicate that (1) several CYP families (CYP2A, CYP2B, CYP2D and CYP3A) could be responsible for the hepatic metabolism of 2-EHA, (2) the same metabolites were formed in rats and man and (3) an unsaturated terminal olefin, 2-ethyl-5-hexenoic acid is formed in the liver.

Key Words: 2-ethylhexanoic acid • cytochrome P450 • man • meta bolism • human liver • microsomes

Human & Experimental Toxicology, Vol. 15, No. 5, 435-442 (1996)
DOI: 10.1177/096032719601500512


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. S. Obach Mechanism of Cytochrome P4503A4- and 2D6-Catalyzed Dehydrogenation of Ezlopitant as Probed with Isotope Effects Using Five Deuterated Analogs Drug Metab. Dispos., December 1, 2001; 29(12): 1599 - 1607. [Abstract] [Full Text] [PDF]

				R. S. Obach Metabolism of Ezlopitant, a Nonpeptidic Substance P Receptor Antagonist, in Liver Microsomes: Enzyme Kinetics, Cytochrome P450 Isoform Identity, and In Vitro-In Vivo Correlation Drug Metab. Dispos., September 1, 2000; 28(9): 1069 - 1076. [Abstract] [Full Text]